160 related articles for article (PubMed ID: 16283682)
1. Pilot study with an intensified oral sirolimus regimen for the prevention of in-stent restenosis in de novo lesions: a serial intravascular ultrasound study.
Chaves AJ; Sousa AG; Mattos LA; Abizaid A; Feres F; Staico R; Centemero M; Tanajura LF; Abizaid AC; Rodrigues A; Paes A; Mintz GS; Sousa JE
Catheter Cardiovasc Interv; 2005 Dec; 66(4):535-40. PubMed ID: 16283682
[TBL] [Abstract][Full Text] [Related]
2. Oral rapamycin to inhibit restenosis after stenting of de novo coronary lesions: the Oral Rapamune to Inhibit Restenosis (ORBIT) study.
Waksman R; Ajani AE; Pichard AD; Torguson R; Pinnow E; Canos D; Satler LF; Kent KM; Kuchulakanti P; Pappas C; Gambone L; Weissman N; Abbott MC; Lindsay J;
J Am Coll Cardiol; 2004 Oct; 44(7):1386-92. PubMed ID: 15464317
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial.
Hausleiter J; Kastrati A; Mehilli J; Vogeser M; Zohlnhöfer D; Schühlen H; Goos C; Pache J; Dotzer F; Pogatsa-Murray G; Dirschinger J; Heemann U; Schömig A;
Circulation; 2004 Aug; 110(7):790-5. PubMed ID: 15302787
[TBL] [Abstract][Full Text] [Related]
4. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation.
Hong MK; Mintz GS; Lee CW; Park DW; Choi BR; Park KH; Kim YH; Cheong SS; Song JK; Kim JJ; Park SW; Park SJ
Eur Heart J; 2006 Jun; 27(11):1305-10. PubMed ID: 16682378
[TBL] [Abstract][Full Text] [Related]
5. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
[TBL] [Abstract][Full Text] [Related]
6. Systemic rapamycin without loading dose for restenosis prevention after coronary bare metal stent implantation.
Stojkovic S; Ostojic M; Nedeljkovic M; Stankovic G; Beleslin B; Vukcevic V; Orlic D; Arandjelovic A; Kostic J; Dikic M; Tomasevic M
Catheter Cardiovasc Interv; 2010 Feb; 75(3):317-25. PubMed ID: 20049961
[TBL] [Abstract][Full Text] [Related]
7. Pilot study of oral rapamycin to prevent restenosis in patients undergoing coronary stent therapy: Argentina Single-Center Study (ORAR Trial).
Rodriguez AE; Alemparte MR; Vigo CF; Pereira CF; Llaurado C; Russo M; Virmani R; Ambrose JA
J Invasive Cardiol; 2003 Oct; 15(10):581-4. PubMed ID: 14519892
[TBL] [Abstract][Full Text] [Related]
8. Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials.
Hoffmann R; Guagliumi G; Musumeci G; Reimers B; Petronio AS; Disco C; Amoroso G; Moses JW; Fitzgerald PJ; Schofer J; Leon MB; Breithardt G
Catheter Cardiovasc Interv; 2005 Dec; 66(4):499-506. PubMed ID: 16273564
[TBL] [Abstract][Full Text] [Related]
9. Comparison of vessel response following sirolimus-eluting stent implantation as assessed by serial 3-D intravascular ultrasound study.
Waseda K; Ako J; Shimada Y; Morino Y; Tsujino I; Hongo Y; Sudhir K; Yock PG; Fitzgerald PJ; Honda Y
J Invasive Cardiol; 2007 Apr; 19(4):171-3. PubMed ID: 17404402
[TBL] [Abstract][Full Text] [Related]
10. Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer.
Grube E; Sonoda S; Ikeno F; Honda Y; Kar S; Chan C; Gerckens U; Lansky AJ; Fitzgerald PJ
Circulation; 2004 May; 109(18):2168-71. PubMed ID: 15123533
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study.
Sousa JE; Costa MA; Abizaid A; Sousa AG; Feres F; Mattos LA; Centemero M; Maldonado G; Abizaid AS; Pinto I; Falotico R; Jaeger J; Popma JJ; Serruys PW
Circulation; 2003 Jan; 107(1):24-7. PubMed ID: 12515737
[TBL] [Abstract][Full Text] [Related]
12. Impact of angiographic and intravascular ultrasound features on clinical outcome after sirolimus-eluting stent implantation for de-novo lesions in nondiabetic and type 2 diabetic patients.
Du R; Zhang RY; Zhu ZB; Zhang Q; Hu J; Yang ZK; Yan ZJ; Lv AK; Ding FH; Zhang JS; Shen WF
Coron Artery Dis; 2010 May; 21(3):175-81. PubMed ID: 20305549
[TBL] [Abstract][Full Text] [Related]
13. Role of oral rapamycin to prevent restenosis in patients with de novo lesions undergoing coronary stenting: results of the Argentina single centre study (ORAR trial).
Rodríguez AE; Rodríguez Alemparte M; Vigo CF; Fernández Pereira C; Llauradó C; Vetcher D; Pocovi A; Ambrose J
Heart; 2005 Nov; 91(11):1433-7. PubMed ID: 15774608
[TBL] [Abstract][Full Text] [Related]
14. Oral rapamycin to prevent human coronary stent restenosis: a pilot study.
Guarda E; Marchant E; Fajuri A; Martínez A; Morán S; Mendez M; Uriarte P; Valenzuela E; Lazen R
Am Heart J; 2004 Aug; 148(2):e9. PubMed ID: 15309012
[TBL] [Abstract][Full Text] [Related]
15. Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions.
Degertekin M; Lemos PA; Lee CH; Tanabe K; Sousa JE; Abizaid A; Regar E; Sianos G; van der Giessen WJ; de Feyter PJ; Wuelfert E; Popma JJ; Serruys PW
Eur Heart J; 2004 Jan; 25(1):32-8. PubMed ID: 14683740
[TBL] [Abstract][Full Text] [Related]
16. Angiographic and volumetric intravascular ultrasound comparison between direct sirolimus-eluting stent implantation versus predilation.
Muñoz JS; Abizaid A; Albertal M; Mintz GS; Graebin R; Feres F; Staico R; Mattos LA; Tanajura LF; Abizaid AS; Sousa A; Sousa JE
Am J Cardiol; 2004 Jun; 93(12):1522-5. PubMed ID: 15194025
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of oral sirolimus to inhibit in-stent intimal hyperplasia.
Brito FS; Rosa WC; Arruda JA; Tedesco H; Pestana JO; Lima VC
Catheter Cardiovasc Interv; 2005 Apr; 64(4):413-8. PubMed ID: 15789385
[TBL] [Abstract][Full Text] [Related]
18. Is there delayed restenosis in patients with coronary artery disease treated with sirolimus-eluting stent?
Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
Coron Artery Dis; 2007 Jun; 18(4):293-8. PubMed ID: 17496493
[TBL] [Abstract][Full Text] [Related]
19. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP;
JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102
[TBL] [Abstract][Full Text] [Related]
20. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
